Markets:

Overview

News

Currencies

International

Treasuries

Cencora, Inc. Common Stock (NY:COR)

320.89 +14.61 (+4.77%)

Streaming Delayed Price Updated: 9:41 AM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Chart Of The Day: Cencora - Name Changed To Protect The Innocent? ↗

January 17, 2024

Cencora, Inc. sources and distributes pharmaceutical products.

Via Talk Markets

How Is The Market Feeling About Cencora? ↗

January 11, 2024

Via Benzinga

Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference ↗

January 10, 2024

Cramer shared his insights during his attendance at JPMorgan's healthcare conference,

Via Benzinga

Topics Artificial Intelligence

Here's How Much You Would Have Made Owning Cencora Stock In The Last 20 Years ↗

January 05, 2024

Via Benzinga

Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release

January 04, 2024

From Cencora

Via Business Wire

If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today ↗

December 18, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Cencora Stock In The Last 15 Years ↗

December 06, 2023

Via Benzinga

(COR) - Analyzing Cencora's Short Interest ↗

December 05, 2023

Via Benzinga

This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks ↗

December 04, 2023

New growth drivers are helping to propel these reliable and steady businesses.

Via The Motley Fool

Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback' ↗

November 29, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would not buy CRISPR Therapeutics AG (NASDAQ: CRSP) stock "all the way up here.

Via Benzinga

Teva Pharma is the way to play the re-rise of generic drugs

November 28, 2023

Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth

Via MarketBeat

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,300 Today ↗

November 21, 2023

Via Benzinga

How Is The Market Feeling About Cencora? ↗

November 17, 2023

Via Benzinga

Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today ↗

October 31, 2023

Via Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today ↗

October 18, 2023

Via Benzinga

Peering Into Cencora's Recent Short Interest ↗

October 17, 2023

Via Benzinga

3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023 ↗

November 14, 2023

The global biotechnology market could nearly triple by 2030. Investors should consider buying these biotech stocks before they explode.

Via InvestorPlace

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

November 09, 2023

From Cencora

Via Business Wire

Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review ↗

November 03, 2023

Bulls are back in control as the major indexes confirmed the uptrend this week.

Via Investor's Business Daily

Peering Into Cencora's Recent Short Interest ↗

September 29, 2023

Via Benzinga

$100 Invested In Cencora 20 Years Ago Would Be Worth This Much Today ↗

September 27, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years ↗

September 12, 2023

Via Benzinga

Obesity And Diabetes Drugs Demand Help Distributor Cencora Propel Revenue In Q3 ↗

November 02, 2023

Cencora Inc's (NYSE: COR), formerly AmerisourceBergen Corporation,

Via Benzinga

Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results

November 02, 2023

From Cencora

Via Business Wire

Earnings Due For Stealth GLP-1 Weight-Loss Drug Play McKesson, Rivals ↗

November 01, 2023

McKesson earnings are on tap, with Cencora and Cardinal Health due soon.

Via Investor's Business Daily

Eli Lilly, McKesson, Novartis Flash Promising Chart Action

October 09, 2023

Eli Lilly, McKesson, and Novartis are catching investors' attention with promising chart patterns and revenue growth, signaling potential buying opportunities.

Via MarketBeat

Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release

October 02, 2023

From Cencora

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

September 01, 2023

On Friday, 57 companies reached new 52-week lows.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Cencora, Inc. Common Stock (NY:COR)

All News about Cencora, Inc. Common Stock

Starting at /week.